Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus

Table 2 Multivariate logistic regression analyses for coronary artery disease in diabetic patients with good and poor glycemic control

Variables		Good glycemic control group			Poor glycemic control group
Variables		OR (95% CI)	P value		OR (95% CI)	P value
	Model 1A			Model 1B
Male		1.492 (0.137–16.197)	0.742		8.47 (0.6–119.56)	0.114
Age		0.973 (0.874–1.084)	0.622		0.953 (0.806–1.126)	0.573
Body mass index		0.882 (0.585–1.328)	0.547		1.592 (0.954–2.656)	0.075
Smoke		1.800 (0.372–8.719)	0.465		3.588 (0.573–22.482)	0.172
Hypertension		7.320 (1.167–45.933)	0.034		3.332 (0.435–25.548)	0.247
Total-to-HDL cholesterol ratio		0.983 (0.503–1.923)	0.960		8.945 (2.004–39.919)	0.004
GFR		0.962 (0.898–1.030)	0.269		0.948 (0.866–1.037)	0.243
Log-transferred hsCRP		0.984 (0.539–1.795)	0.958		1.415 (0.701–2.857)	0.333
	Model 2A			Model 2B
Male		2.668 (0.187–38.168)	0.470		14.289 (0.707–288.728)	0.083
Age		0.949 (0.849–1.061)	0.358		0.934 (0.774–1.126)	0.473
Body mass index		0.970 (0.622–1.513)	0.894		1.753 (0.943–3.258)	0.076
Smoke		2.408 (0.458–12.679)	0.300		3.725 (0.501–27.674)	0.199
Hypertension		8.476 (1.202–59.789)	0.032		5.577 (0.470–66.239)	0.173
Total-to-HDL cholesterol ratio		1.158 (0.562–2.389)	0.691		11.882 (1.713–82.402)	0.012
GFR		0.964 (0.899–1.034)	0.303		0.941 (0.847–1.046)	0.261
Log-transferred hsCRP		0.815 (0.423–1.570)	0.540		1.015 (0.462–2.228)	0.971
Tertiles of FMD		0.410 (0.128–1.307)	0.132		0.227 (0.056–0.915)	0.037

Values are odds ratios (95% confidence interval)
FMD flow-mediated dilation, GFR glomerular filtration rate, HDL high-density lipoprotein, hsCRP high-sensitivity C-reactive protein

ISSN: 1475-2840